NCT05769621招募中不适用
A Retrospective Cohort Study to Characterize Propionic Acidemia Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 46
- 主要终点
- Number of Annualized Clinical Event Committee (CEC)-adjudicated Metabolic Decompensation Events (MDEs)
研究概览
简要总结
This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA).
详细描述
Data will be abstracted through medical record review ensuring inclusion only of data from participants meeting all the inclusion criteria and none of the censoring criteria. Data will be collected retrospectively from study sites, including medical clinics, hospitals and academic medical centers.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 2 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants' medical records are eligible for abstraction only if all of the following criteria apply:
- •Confirmed diagnosis of PA based on diagnosis by molecular genetic testing (propionyl-CoA carboxylase subunitα[PCCA] and/or propionyl-CoA carboxylase subunitβ[PCCB] mutations).
- •Participant provided informed consent (and assent, as applicable).
- •Medical records with sufficient data to support medical encounter for CEC adjudication (MEA adjudication) must be available dating back to birth or 01 January 2015, whichever occurs later. Participants born prior to 2015 will require additional information to confirm eligibility.
- •Experienced at least one MDE in the 24 months preceding the Index Date or experienced at least 3 MDEs within any one 12-month retrospective review period (based on Index Date) dating back to birth or 01 January 2015, whichever occurs later.
- •Must have a confirmed age (months) of disease onset (early or late, where early is defined as the neonatal period).
- •Participants who meet any of the censoring criteria listed below may be enrolled into the study if they have a minimum of 2 years of data available for abstraction prior to meeting the censoring criteria and they meet all inclusion criteria based on the data available for abstraction.
- •Censoring Criteria:
- •Participants medical records meeting the following censoring criterion will not be abstracted:
- •Participation in a clinical study of any investigational agent.
- •Received gene therapy treatment
- •Confirmed organ transplantation
- •Investigator is no longer able to obtain relevant clinical information of the participant.
排除标准
- •Participant's medical records will not be eligible for abstraction if the participant meets the following exclusion criteria:
- •- Participation (prior or ongoing) in clinical study mRNA-3927-P101 (NCT04159103) or mRNA-3927-P101-EXT (NCT05130437).
研究组 & 干预措施
PA Participants
Participants with PA who meet all eligibility criteria for medical record abstraction.
结局指标
主要结局
Number of Annualized Clinical Event Committee (CEC)-adjudicated Metabolic Decompensation Events (MDEs)
时间窗: Up to 10 years
次要结局
- Number of CEC-adjudicated MDEs as Assessed by a Pre-Specified Severity Rating Scale(Up to 10 years)
- Number of Annualized CEC-adjudicated PA-related Hospitalizations(Up to 10 years)
- Number of Annualized CEC-adjudicated MDE-related Hospitalizations(Up to 10 years)
- Number of Annualized CEC-adjudicated PA-related Urgent Healthcare Visits(Up to 10 years)
研究者
研究点 (46)
Loading locations...
相似试验
已完成
不适用
Retrospective Study in a NSCLC M+ pEGFR Mutated Non-small Cell Lung Cancer PatientsNCT01795352AstraZeneca187
招募中
不适用
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United KingdomChronic Lymphocytic Leukemia, CLLNCT05557695AstraZeneca287
已完成
不适用
A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in ChinaHyperkalaemiaNCT05271266AstraZeneca1,000
已完成
不适用
An Non-Interventional Study of Patients With Persistent Symptoms of SchizophreniaSchizophreniaNCT01634542Hoffmann-La Roche1,433
已完成
不适用
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of RussiaArterial Hypertension, Chronic Kidney DiseaseNCT06372431AstraZeneca9,914